Baird Initiates Coverage on Several Medical Instruments & Supplies Stocks
More News related to BCR
- Morgan Keegan Starts BDX, HAE, BCR, MASI, COO at Outperform, BAX, HRC, COV, TFX, ISRG at Market Perform
- Bard to Host December 2009 Investor Conference
- CR Bard (BCR) Tops Q3 EPS by 3c
- Bard Announces Third Quarter Results
- Barclays Starts Stocks in Medical Equipment Group: EW, COV, MDT, ZMH at Overweight, SYK, BCR at Underweight
More News related to BSX
- Boston Scientific to Participate in Piper Jaffray Health Care Conference
- Boston Scientific (BSX) Receives 510(k) Clearance and CE Mark on WallFlex
- Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent
- UBS Upgrades Boston Scientific (BSX) to Buy
- Trading Review for Viking Systems Inc. Issued by Beacon Equity
More News related to EW
- Morgan Joseph Initiates Coverage on Edwards Lifesciences (EW) with a Hold; High-Quality Mid-Cap Growth Name
- Edwards Lifesciences Honors Dr. William Ganz' Contributions to Patient Care
- The Edwards Lifesciences Fund to Grant $4.6 Million to Nonprofit Organizations in 2009
- First Transcatheter Valve Cases in Japan Performed With Edwards SAPIEN Valve
- Edwards Lifesciences to Present at the Credit Suisse Annual Healthcare Conference
More News related to New Coverage
- Pritchard Capital Initiates Coverage on Construction Services Stocks
- Sidoti & Co Initiates Coverage on Scholastic (SCHL) with a Buy
- Raymond James Initiates Coverage on Movie Production, Theater Stocks
- C. K. Cooper & Company Initiates Coverage on Atwood Oceanics (ATW) with a Buy
- Macquarie Initiates Coverage on Comverge (COMV) with an Outperform
Baird initiates coverage on Boston Scientific (NYSE: BSX) with an Outperform rating and a $13 price target.
Baird initiates coverage on the following companies with a 'Neutral' rating: C.R. Bard (NYSE: BCR) PT $79; Edwards Lifesciences (NYSE: EW) PT $64; Medtronic (NYSE: MDT) PT $34; and St. Jude (NYSE: STJ) PT $40.
Related Categories
New CoverageStocks Mentioned
+0.47
-0.13Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
